Depression, anxiety and quality of life in subjects with atopic eczema in a population-based cross-sectional study in Germany.
Atopic eczema (AE) may be associated with several mental health problems. In Germany, existing data fom selected patient cohorts may lead to misestimation of the problem. We aimed to cross-sectionally determine associations of AE with depression, anxiety, quality of life (QoL) and social interactions in subjects from the population-based LIFE-Adult-Study. Subjects underwent standardized interviews (medical history) and answered standardized questionnaires (Centre of Epidemiologic studies-Depression scale/CES-D, Generalized Anxiety Disorder/GAD-7, Lubben Social Network Scale/LSNS, Short Form Health Survey /SF-8). We compared data from subjects with AE with those from subjects with selected other chronic/disabling diseases (cardiovascular, diabetes, cancer) and adjusted for selected sociodemographic parameters. Multivariate binary logistic regression was used for categorical variables, linear regression for continuous variables. Out of 9,104 adults included (57% female, median age 54 years), 372 (4.1%) had a history of AE. Compared with controls, subjects with AE showed higher scores for depressive symptoms (9.3 vs. 6.3%; p<0.001) and anxiety (8.4 vs. 5.6%, p<0.001). Odds ratio (OR) was 1.5 [CI 1.0; 2.3] (p=0.031) for depression, which was comparable to OR in patients with a history of cancer (OR 1.6 [1-2.3], p=0.001. OR for anxiety in AE was 1.5 [1.0; 2.2], p< 0.049, which was slightly higher than in diabetes mellitus (OR 1.2) and stroke (OR 1.4). Other than in diabetes and/or stroke we did not find a significant association between AE and social isolation. QoL scores were lower in AE than in controls (mean 46.9 vs. 48.0, p<0.001 for physical and 50.6 vs. 52.5, p<0.001 for mental components). Subjects with AE showed higher values for depression and anxiety as well as lower QoL scores compared to controls. With regard to depression, odds in AE and cancer were hardly different. Medical care of AE patients should therefore include mental health evaluation and treatment if indicated.